Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebban

Showing results (341-350 of 459) with videos related to

Pageof 46
Sort By:
Nature Communications|February 25, 2015
Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactionsJeremy Bonzi, Olivier Bornet, Stephane Betzi, et al.
Presse Medicale (Paris, France : 1983)|January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]C Fermé, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammationLora Eshkar Sebban, Denise Ronen, David Levartovsky, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Cell Reports|July 26, 2024
Pre-B cell receptor acts as a selectivity switch for galectin-1 at the pre-B cell surfacePauline Touarin, Bastien Serrano, Audrey Courbois, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
Hematological Oncology|February 6, 2014
Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-upEmmanuelle Nicolas-Virelizier, Céline Ségura-Ferlay, Herve Ghesquières, et al.
Leukemia|March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.
Nature Communications|June 17, 2022
Comparative parallel multi-omics analysis during the induction of pluripotent and trophectoderm statesMohammad Jaber, Ahmed Radwan, Netanel Loyfer, et al.
Pageof 46

Showing results (341-350 of 459) with videos related to

Sort By:
Pageof 46
Nature Communications|February 25, 2015
Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactionsJeremy Bonzi, Olivier Bornet, Stephane Betzi, et al.
Presse Medicale (Paris, France : 1983)|January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]C Fermé, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammationLora Eshkar Sebban, Denise Ronen, David Levartovsky, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Cell Reports|July 26, 2024
Pre-B cell receptor acts as a selectivity switch for galectin-1 at the pre-B cell surfacePauline Touarin, Bastien Serrano, Audrey Courbois, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
Hematological Oncology|February 6, 2014
Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-upEmmanuelle Nicolas-Virelizier, Céline Ségura-Ferlay, Herve Ghesquières, et al.
Leukemia|March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.
Nature Communications|June 17, 2022
Comparative parallel multi-omics analysis during the induction of pluripotent and trophectoderm statesMohammad Jaber, Ahmed Radwan, Netanel Loyfer, et al.
Pageof 46